Arch Therapeutics (ARTH) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free ARTH Stock Alerts $1.05 +0.01 (+0.96%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 2:06 AM | americanbankingnews.comShort Interest in Arch Therapeutics, Inc. (OTCMKTS:ARTH) Decreases By 5.3%May 10, 2024 | americanbankingnews.comArch Therapeutics (OTCMKTS:ARTH) Stock Passes Below Fifty Day Moving Average of $1.60May 6, 2024 | globenewswire.comArch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)February 8, 2024 | msn.comArch Therapeutics Secures $750K Prepayment for StockJanuary 6, 2024 | morningstar.comArch Therapeutics Inc ARTHNovember 23, 2023 | msn.comAre Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?November 9, 2023 | finanznachrichten.deArch Therapeutics, Inc.: Arch Therapeutics Provides Year End Operational UpdateNovember 9, 2023 | finance.yahoo.comArch Therapeutics Provides Year End Operational UpdateNovember 2, 2023 | finance.yahoo.comArch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)September 13, 2023 | finance.yahoo.comArch Therapeutics Provides AC5® Commercialization UpdateSeptember 8, 2023 | finanznachrichten.deArch Therapeutics, Inc.: Arch Therapeutics Completes Financing as Bridge to UplistingSeptember 7, 2023 | finance.yahoo.comArch Therapeutics Completes Financing as Bridge to UplistingJuly 8, 2023 | health.usnews.comDr. Arth PatelJune 13, 2023 | travel.usnews.comDouble ArchApril 25, 2023 | finance.yahoo.comArch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)April 5, 2023 | finance.yahoo.comDedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In EffectMarch 20, 2023 | investing.comArch Therapeutics Inc (ARTHD)March 9, 2023 | finance.yahoo.comArch Therapeutics’ AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid ServicesMarch 7, 2023 | finance.yahoo.comArch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government FacilitiesFebruary 23, 2023 | benzinga.comArch Therapeutics Inc Stock (OTC:ARTHD), Earnings Estimates, EPS, and RevenueJanuary 24, 2023 | msn.comWound products developer Arch Therapeutics files for uplisting, $35M offering (update)January 18, 2023 | finanznachrichten.deArch Therapeutics, Inc.: Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National ExchangeJanuary 18, 2023 | finance.yahoo.comArch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound SystemJanuary 17, 2023 | finance.yahoo.comArch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National ExchangeDecember 5, 2022 | finance.yahoo.comThe Centers for Medicare & Medicaid Services Makes Preliminary Recommendation to Establish New HCPCS Billing Code Dedicated to Arch Therapeutics’ AC5® Advanced Wound SystemOctober 20, 2022 | seekingalpha.comARTH Arch Therapeutics, Inc.October 18, 2022 | yahoo.comKey Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) FallOctober 11, 2022 | finance.yahoo.comArch Therapeutics’ AC5® Advanced Wound System to be Presented with Honors at 2022 Symposium on Advanced Wound Care (SAWC) FallSeptember 23, 2022 | finance.yahoo.comArch Therapeutics Announces First Shipments of AC5® Advanced Wound System Under New Reimbursement Support ProgramSeptember 16, 2022 | finance.yahoo.comArch Therapeutics Announces Intent to Uplist from OTC to a National ExchangeSeptember 7, 2022 | finance.yahoo.comArch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound SystemJuly 14, 2022 | benzinga.comArch Therapeutics (OTC:ARTH), Short Interest ReportJuly 7, 2022 | finance.yahoo.comArch Therapeutics Raises Approximately $3.5 Million in Convertible Note FinancingJune 22, 2022 | finance.yahoo.comArch Therapeutics Provides Update on Reimbursement Strategy in Additional Selling ChannelMay 9, 2022 | finance.yahoo.comArch Therapeutics’ Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC SpringMay 9, 2022 | benzinga.comArch Therapeutics' Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC SpringApril 13, 2022 | finance.yahoo.comRenowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) SpringApril 4, 2022 | finance.yahoo.comArch Therapeutics’ AC5® Advanced Wound System to be Presented at 2022 Symposium on Advanced Wound Care (SAWC) SpringMarch 14, 2022 | finance.yahoo.comArch Therapeutics Partners with Centurion Therapeutics to Expand Access to AC5® Advanced Wound SystemJanuary 6, 2022 | finance.yahoo.comClinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant ComorbiditiesJanuary 4, 2022 | finance.yahoo.comArch Therapeutics Announces Appointment of Guy Fish to the BoardDecember 13, 2021 | finance.yahoo.comArch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound SystemDecember 1, 2021 | finance.yahoo.comArch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care ProgramNovember 1, 2021 | finance.yahoo.comArch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium on Advanced Wound Care (SAWC)October 25, 2021 | finance.yahoo.comArch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) FallOctober 18, 2021 | finance.yahoo.comArch Therapeutics Launches Experts in Wound Care ProgramOctober 13, 2021 | finance.yahoo.comArch Therapeutics Provides Corporate UpdateOctober 6, 2021 | finance.yahoo.comArch Therapeutics to Present at the LD Micro Main EventOctober 4, 2021 | finance.yahoo.comArch Therapeutics Launches Coverage and Reimbursement PilotSeptember 30, 2021 | finance.yahoo.comArch Therapeutics Announces Appointment of Larry Hicks to the Board Get Arch Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction … Stop right now and do these 3 things to protect yourself ARTH Media Mentions By Week ARTH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARTH News Sentiment▼0.990.49▲Average Medical News Sentiment ARTH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARTH Articles This Week▼20▲ARTH Articles Average Week Get Arch Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TMDIF News Today VAPO News Today VERO News Today UAHC News Today SIGY News Today TNON News Today AVGR News Today STSS News Today INVO News Today QNRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ARTH) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arch Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
